Support women in science at Burnet Institute
Donate today to support women in science at Burnet and their work to unlock the vaginal microbiome and reduce risk of HIV infection and preterm birth for women around the world.
HIV and AIDS, 2000 (13)
October, 2000 (1)
- Live attenuated HIV vaccines: a proposal for further research and development.
Mills J, Desrosiers R, Rud E, Almond N
AIDS Res Hum Retroviruses. 2000 Oct; 16(15):1453-1461
September, 2000 (2)
- Macrophage infection by HIV-1: focus on viral reservoirs and pathogenesis
Montaner LJ, Perno CF, Crowe S
J Leukoc Biol. 2000 Sep; 68(3):301-302 - HIV-1 can be recovered from a variety of cells including peripheral blood monocytes of patients receiving highly active antiretroviral therapy: a further obstacle to eradication.
Crowe SM, Sonza S
J Leukoc Biol. 2000 Sep; 68(3):345-350
August, 2000 (3)
- Granulocyte-macrophage colony-stimulating factor inhibits HIV-1 replication in monocyte-derived macrophages.
Kedzierska K, Maerz A, Warby T, Jaworowski A, Chan H, Mak J, Sonza S, Lopez A, Crowe S
AIDS. 2000 Aug; 14(12):1739-1748 - Induction of HIV-1-specific T-helper responses and type 1 cytokine secretion following therapeutic vaccination of macaques with a recombinant fowlpoxvirus co-expressing interferon-gamma.
Dale CJ, Zhao A, Jones SL, Boyle DB, Ramshaw IA, Kent SJ
J Med Primatol. 2000 Aug; 29(3-4):240-247 - Late presentation of HIV infection associated with prolonged survival following AIDS diagnosis--characteristics of individuals.
Hocking JS, Rodger AJ, Rhodes DG, Crofts N
Int J STD AIDS. 2000 Aug; 11(8):503-508
July, 2000 (1)
- HIV-1 Nef: a critical factor in viral-induced pathogenesis.
Greenway AL, Holloway G, McPhee DA
Adv Pharmacol. 2000 Jul; 48:299-343
March, 2000 (1)
- Rapid full-length genomic sequencing of two cytopathically heterogeneous Australian primary HIV-1 isolates.
Oelrichs RB, Lawson VA, Coates KM, Chatfield C, Deacon NJ, McPhee DA
J Biomed Sci. 2000 Mar; 7(2):128-135
February, 2000 (3)
- The explosive human immunodeficiency virus type 1 epidemic among injecting drug users of Kathmandu, Nepal, is caused by a subtype C virus of restricted genetic diversity.
Oelrichs RB, Shrestha IL, Anderson DA, Deacon NJ
J Virol. 2000 Feb; 74(3):1149-1157 - A compilation of cellular transcription factor interactions with the HIV-1 LTR promoter.
Pereira LA, Bentley K, Peeters A, Churchill MJ, Deacon NJ
Nucleic Acids Res. 2000 Feb; 28(3):663-668 - Efficacy and kinetics of glycerol inactivation of HIV-1 in split skin grafts.
Cameron PU, Pagnon JC, van Baare J, Reece JC, Vardaxis NJ, Crowe SM
J Med Virol. 2000 Feb; 60(2):182-188
January, 2000 (2)
- Visualisation of phenotypically mixed HIV-1 and HTLV-I virus particles by electron microscopy.
Lawson VA, Lee JY, Doultree JC, Marshall JA, McPhee DA
J Biomed Sci. 2000 Jan; 7(1):71-74 - Granulocyte-macrophage colony-stimulating factor augments phagocytosis of Mycobacterium avium complex by human immunodeficiency virus type 1-infected monocytes/macrophages in vitro and in vivo.
Kedzierska K, Mak J, Mijch A, Cooke I, Rainbird M, Roberts S, Paukovics G, Jolley D, Lopez A, Crowe SM
J Infect Dis. 2000 Jan; 181(1):390-394
Year
- 2023
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
- 2013
- 2012
- 2011
- 2010
- 2009
- 2008
- 2007
- 2006
- 2005
- 2004
- 2003
- 2002
- 2001
- 2000
- 1999
- 1998
- 1997
- 1996
- 1995
- 1994
- 1993
- 1992
- 1991
- 1990
- 1989
- 1988
- 1987
- 1982
- 1981
- 1955
Program
- All
- Executive (0)
- Healthy Mothers, Healthy Babies (HMHB) (0)
- Towards Eliminating HIV (0)
- Strategic Funding & Partnerships Executive Team (0)
- Disease Elimination (0)
- Maternal, Child and Adolescent Health (0)
- Philanthropy and Supporter Engagement (0)
- Health Security and Pandemic Preparedness (0)
- Eliminate Malaria (0)
- Eliminate Tuberculosis (TB) (0)
- Finance (0)
- Healthy Ageing (0)
- Human Resources (0)
- Burnet Honorary Research Fellows (0)
- Research Support and Facilities (0)
- Harm Reduction (0)
- Information Technology (0)
- Burnet Vaccine Initiative (0)
- Laboratory Services (0)
- Eliminate Viral Hepatitis (0)
- Education & Training (0)
- Infectious Diseases Elimination (0)
- Support Services Group (0)
- Project Management and Quality Assurance Office (0)
- Marketing and Communications (0)
- International Operations (0)
- Commercialisation, Innovation and Industry Partnerships (0)
Discipline
- All
- Life Sciences (0)
- Public Health (0)
- International Development (0)
Research Theme
- All
- HIV and AIDS (13)
- Immune Disease and Cancer (20)
- Hepatitis B (6)
- Hepatitis C (4)
- Global infectious disease threats (1)
- Injecting Drug Use (1)
- Alcohol and Other Drugs (1)
